References
- Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. Lancet 2016; 387: 1094-108. doi: 10.1016/S0140-6736(15)00130-0
- Bray F, Dos Santos Silva I, Moller H, Weiderpass E. Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention. Cancer Epidemiol Biomarkers Prev 2005; 14: 1132-42. doi: 10.1158/1055-9965.EPI-04-0871
- Siegel R, Miller KD, Jemal A. Cancer statistics 2015. CA Cander J Clin 2015; 65: 5-29. doi: 10.3322/caac.21254
- Galceran J, Ameijide A, Carulla M, Mateos A, Quirós JR, Rojas D, et al. REDECAN Working Group. Cancer incidence in Spain, 2015. Clin Transl Oncol 2017; 19: 799-825. doi: 10.1007/s12094-016-1607-9
- Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet 2009; 105: 109. doi: 10.1016/j.ijgo.2009.02.010
- Beddy P, O’Neill AC, Yamamoto AK, Addley HC, Reinhold C, Sala E. FIGO staging system for endometrial cancer: added benefits of MR imaging. Radiographics 2012; 32: 241-54. doi: 10.1148/rg.321115045
- Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 2008; 109: 11-8. doi: 10.1016/j.ygyno.2008.01.023
- Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, et al. ESMO-ESGO-ESTRO Endometrial Consensus Conference Working Group. ESMO-ESGO-ESTRO Consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Int J Gynecol Cancer 2016; 26: 2-30. doi: 10.1097/IGC.0000000000000609.
- Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 2000; 182: 1506-19. doi: 10.1067/mob.2000.107335
- Alhilli, MM, Podratz KC, Dowdy SC, Bakkum-Gamez JN, Weaver AL, McGree ME et al. Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer. Gynecol Oncol 2013; 128: 294-9. doi: 10.1016/j.ygyno.2012.10.009
- Coronado PJ, Rychlik A, Martínez-Maestre MA, Baquedano L, Fasero M, García-Arreza A, et al. Role of lymphadenectomy in intermediate-risk endometrial cancer: a matched-pair study. J Gynecol Oncol 2018; 29: e1. doi: 10.3802/jgo.2018.29e1
- Coronado PJ, Fasero M, Baquedano L, Martinez-Maestre MA, Casado A, Vidart JA, et al. Impact of the lymphadenectomy in high-risk histologic types of endometrial cancer: a matched-pair study. Int J Gynecol Cancer 2014; 24: 703-12. doi: 10.1097/IGC.0000000000000120
- TNM atlas. Illustrated guide to the TNM/pTNM classification of malignant tumours In: Writtekind Ch, Greene FL, Hutter RVP, Klimpfinger M, Sobin LH, editors. 5th edition. Berlin, Heidelberg: Springer-Verlag; 2004.
- Milam MR, Java J, Walker JL, Metzinger DS, Parker LP, Coleman RL. Gynecologic Oncology Group. Nodal metastasis risk in endometrioid endometrial cancer. Obstet Gynecol 2012; 119: 286-92. doi: 10.1097/AOG.0b013e318240de51
- Todo Y, Sakuragi N, Nishida R, Yamada T, Ebina Y, Yamamoto R, Fujimoto S. Combined use of magnetic resonance imaging, CA 125 assay, histologic type, and histologic grade in the prediction of lymph node metastasis in endometrial carcinoma. Am J Obstet Gynecol 2003; 188: 1265-72. doi: 10.1067/mob.2003.318
- Todo Y, Okamoto K, Hayashi M, Minobe S, Nomura E, Hareyama H, et al. A validation study of a scoring system to estimate the risk of lymph node metastasis for patients with endometrial carcinoma for tailoring the indication of lymphadenectomy. Gynecol Oncol 2007; 104: 623-8. doi: 10.1016/j.ygyno.2006.10.002
- Oncoguía SEGO (ES). [Guide of practice clinic in cancer gynaecology and senology]. [Spanish]. Madrid: Publicaciones SEGO; 2010.
- Todo Y, Watari H, Okamoto K, Hareyama H, Minobe S, Kato H, et al. Tumor volume successively reflects the state of disease progression in endometrial cancer. Gynecol Oncol 2013; 129: 472-7. doi: 10.1016/j.ygyno.2013.02.034
- Todo Y, Choi HJ, Kang S, Kim JW,Nam JH, Watari H, et al. Clinical significance of tumor volume in endometrial cancer: a Japan-Korea cooperate study. Gynecol Oncol 2013; 131: 294-8. doi: 10.1016/j.ygyno.2013.08.008
- Chung HH, Lee I, Kim HS, Kim JW, Park NH, Song YS, et al. Prognostic value of preoperative metabolic tumor volume measured by 18F-FDG PET/CT and MRI in patients with endometrial cancer. Gynecol Oncol 2013; 130: 446-51. doi: 10.1016/j.ygyno.2013.06.021
- Guo Y, Wang P, Wang P, Gao W, Li F, Yang X, et al. Myometrial invasion and overall staging of endometrial carcinoma: assessment using fusion of T2-weighted magnetic resonance imaging and diffusion-weighted magnetic resonance imaging. Onco Targets Ther 2017; 10: 5937-43. doi: 10.2147/OTT.S145763
- Frühauf F, Zikan M, Semeradova I, Dundr P, Nemejcova K, Dusek L, et al. The diagnostic accuracy of ultrasound in assessment of myometrial invasion in endometrial cancer: subjective assessment versus objective techniques. Biomed Res Int 2017; 2017: 1318203. doi: 10.1155/2017/1318203
- Ruiz R, Gorostidi M, Jaunarena I, Goiri C, Aguerre J, Lekuona A. Sentinel node biopsy in endometrial cancer with dual cervical and fundal indocyanine green injection. Int J Gynecol Cancer 2018; 28: 139-44. doi: 10.1097/IGC.0000000000001151